Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

Kimberly-Clark: Thomas J. Mielke, formerly VP and chief counsel for Kimberly-Clark's North Atlantic consumer business, has been named senior VP of law, government affairs and chief compliance officer, reporting to CEO Thomas J. Falk. Mielke succeeds Ronald D. McCray, who recently resigned to join Nike. Mielke, who joined Kimberly-Clark in 1988, has extensive U.S. and international patent, trademark and general litigation experience...

You may also be interested in...



Hershey for health

Hershey is launching the Hershey Center for Health & Nutrition to develop products that will offer consumers "health benefits in the areas of heart health, weight management, and mental and physical energy," the firm announces May 9. "Our goal is to redefine the future of snacking by offering consumers products that provide proven health benefits," Hershey Senior VP Tom Hernquist said. "Our research is validating the significant health benefits of cocoa and snack nuts and, combined with our proven ability to develop and commercialize innovative new products, provides an immense capability to meet the growing consumer demand for healthier products"...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100985

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel